Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 66,382 | 65,183 | 107,399 | 96,669 | 65,632 |
| Cost of Goods | 20,551 | 16,129 | 40,767 | 44,386 | 36,432 |
| Gross Profit | 45,831 | 49,054 | 66,632 | 52,283 | 29,200 |
| Operating Expenses | 54,209 | 50,774 | 84,464 | 162,575 | 88,502 |
| Operating Income | -7,827 | -1,591 | -17,065 | -109,906 | -58,870 |
| Interest Expense | 3,703 | 5,059 | 4,963 | 0 | 0 |
| Other Income | -2,215 | -3,728 | 4,977 | 1,017 | 840 |
| Pre-tax Income | -13,745 | -10,378 | -17,051 | -108,889 | -58,030 |
| Income Tax | 437 | 2,142 | 0 | -110 | 259 |
| Net Income Continuous | -14,182 | -12,520 | -17,051 | -108,779 | -58,289 |
| Net Income Discontinuous | 620 | -3,324 | N/A | N/A | N/A |
| Net Income | $-13,562 | $-15,844 | $-17,051 | $-108,779 | $-58,289 |
| EPS Basic Total Ops | -2.16 | -2.86 | -5.11 | -74.01 | -69.60 |
| EPS Basic Continuous Ops | -2.26 | -2.26 | -5.11 | -74.00 | -69.61 |
| EPS Basic Discontinuous Ops | 0.10 | -0.60 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -2.16 | -2.86 | -5.11 | -74.01 | -69.60 |
| EPS Diluted Continuous Ops | -2.26 | -2.26 | -5.11 | -74.00 | -69.61 |
| EPS Diluted Discontinuous Ops | 0.10 | -0.60 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.34 | -2.86 | -3.52 | -34.40 | -47.20 |
| EBITDA(a) | $-2,342 | $5,731 | $-7,691 | $-24,428 | $-36,888 |